Mass General Brigham Scientists Develop Non-Toxic "INSTALL" Method to Insert Large DNA Sequences Into Human Genomes

New INSTALL technology allows for safe, non-toxic insertion of large DNA sequences, overcoming immune barriers that previously hindered universal gene therapies.

By: AXL Media

Published: Mar 13, 2026, 7:38 AM EDT

Source: Information for this report was sourced from Mass General Brigham

A Universal Strategy for Scaling Genetic Disease Treatment

Current genome editing therapies often focus on correcting specific, individual mutations within a patient's cells. However, because many genetic disorders are caused by thousands of unique variations across a single gene, developing customized treatments for every patient is a significant challenge of scale. Researchers from Mass General Brigham have proposed a more universal solution: the precise insertion of an entire healthy copy of a gene into a specific genomic location. This method, described in the journal Nature, could theoretically provide a single treatment for all patients regardless of where their specific mutation lies within the targeted gene.

Overcoming the Toxicity of Double-Stranded DNA Integration

A major obstacle in large-scale genome writing has been the innate immune system's reaction to the delivery of corrective DNA. Traditional methods rely on double-stranded DNA (dsDNA) cargo, which the body often identifies as a viral threat, triggering dangerous and sometimes fatal immune responses. These reactions limit the dosage and efficacy of therapies delivered directly into the body. Senior author Benjamin P. Kleinstiver, PhD, noted that the study’s primary breakthrough is demonstrating that large-scale integration is now possible without these toxic side effects or the high costs and safety concerns associated with viral vectors.

The "Stealth" Mechanics of Single-Stranded DNA Circles

The research team discovered that circular molecules comprised of only a single strand of DNA are capable of evading immune detection. However, most recombinase enzymes—the tools used to "stitch" new DNA into the genome—require a double-stranded structure to function. To solve this compatibility issue, the team designed a hybrid configuration called INSTALL. This system uses a DNA circle that is primarily single-stranded to maintain a "stealth" profile, but includes a very short double-stranded region. This double-stranded segment is just long enough for the recombinase to recognize and bind to it, yet small enough to remain invisible to the body’s immune sensors.